MedPath

Laminar, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:2
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Not Applicable
Active, not recruiting
Conditions
Atrial Fibrillation
First Posted Date
2022-02-04
Last Posted Date
2025-07-16
Lead Sponsor
Laminar, Inc.
Target Recruit Count
29
Registration Number
NCT05224375
Locations
🇬🇪

Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia

Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System

Not Applicable
Active, not recruiting
Conditions
Atrial Fibrillation
First Posted Date
2021-03-19
Last Posted Date
2023-10-03
Lead Sponsor
Laminar, Inc.
Target Recruit Count
29
Registration Number
NCT04807283
Locations
🇬🇪

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi, Georgia

🇬🇪

Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia

🇵🇾

Sanatorio Italiano Hospital, Asunción, Paraguay

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.